Skip to main content
Fig. 5 | Molecular Neurodegeneration

Fig. 5

From: Affinity of Tau antibodies for solubilized pathological Tau species but not their immunogen or insoluble Tau aggregates predicts in vivo and ex vivo efficacy

Fig. 5

4E6, but not 6B2, prevented neurotoxicity induced by 10 μg/ml PHF. a–c NeuN immunoblots from samples treated with 10 μg/ml PHF alone and with PHF and 1 μg/ml a 4E6, B 6B2 or c control mouse IgG1. d Quantitation of signal in samples treated with PHF alone and a combination of PHF and 4E6. At 10 μg/ml, PHF alone reduced NeuN levels by 94 % relative to untreated control cells (p < 0.0001). PHF + Ab and PHF → Ab paradigms resulted in NeuN levels significantly higher than those incubated with PHF alone (116 and 124 % control, p < 0.0001 for both) and were comparable to control levels. However, the Ab → PHF paradigm was ineffective and showed a significantly reduced NeuN signal relative to control (93 % loss, p < 0.0001) and no improvement over PHF alone samples. e 6B2 did not prevent NeuN loss under any of the dosing conditions used. None of the groups were significantly improved relative to PHF alone. f Similar to the 6B2 samples, the control IgG1 did not protect against the PHF induced loss of NeuN and these samples were similar to the PHF alone group

Back to article page